Home › Chronic Pain › NCT06119698
Improving Health for Older Adults With Pain Through Engagement
Randomized, Hybrid Type 1 Effectiveness-implementation Trial of GetActive+ vs Treatment as Usual; iHOPE Study
Who can join
Ages 55 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Older Adults (i.e., age \>=55) 2. Diagnosed musculoskeletal chronic pain of any type (e.g., pain \> 3 months) 3. Pain score \>=4 (moderate) on the Numerical Rating Scale 4. Cognitively able to participate as measured by the Short Portable Mental Health questionnaires (e.g., \<4 errors) 5. Self-reported ability to complete the 6-minute walk test including with assistive devices 6. Patient at Revere HealthCare Center or MGH Broadway Primary Care in Revere who is cleared for participation by medical staff 7. English or Spanish fluency and literacy Exclusion Criteria: 1. Current serious medical illness that is expected to worsen in the next 6 months (e.g., cancer) 2. Individuals who are unwilling or unable to comply with study procedures including wearing a smartwatch 3. Active suicidal ideation with plan or intent 4. Active and untreated serious mental health or substance use disorder
About the study
The goal of this project is to conduct a randomized, hybrid type 1 effectiveness-implementation trial (N=200) to evaluate the effectiveness and implementation of a 10-week mind-body and walking program (GetActive+) vs treatment as usual (TAU). The investigators will test for improvements in self-reported, performance-based (i.e., six-minute walk test), and objective (i.e., step-count) physical function, emotional function, as well as feasibility, acceptability and implementation markers. Participants will complete measures at baseline (0 weeks), post-intervention (1 week after intervention completion), and 6-month follow-up.
This study will receive support from and inclusion in the HEAL Initiative (https://heal.nih.gov/).
What is being tested
- GetActive+ (behavioral)
Sponsor: Massachusetts General Hospital · Participants: 200 · Started: Oct 1, 2024
Contact the study team
- Ana-Maria Vranceanu, PhD · Phone: 617-724-4977
- Christine Ritchie, MD, MPH · Phone: 617-726-1382
Official record on ClinicalTrials.gov — NCT06119698
Locations in the U.S.
| Massachusetts | Massachusetts General Hospital, Boston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.